136 related articles for article (PubMed ID: 21683367)
1. Mass spectrometric characterization of urinary toremifene metabolites for doping control analyses.
Gómez C; Pozo OJ; Diaz R; Sancho JV; Vilaroca E; Salvador JP; Marco MP; Hernandez F; Segura J; Ventura R
J Chromatogr A; 2011 Jul; 1218(29):4727-37. PubMed ID: 21683367
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric characterization of toremifene metabolites in human urine by liquid chromatography-tandem mass spectrometry with different scan modes.
Lu J; Wang X; Xu Y; Dong Y; Yang S; Wu Y; Qin Y; Wu M
Analyst; 2011 Feb; 136(3):467-72. PubMed ID: 21113546
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion profiles of toremifene metabolites by liquid chromatography-mass spectrometry. Towards targeted analysis to relevant metabolites in doping control.
Mazzarino M; de la Torre X; Botrè F
Anal Bioanal Chem; 2011 Aug; 401(2):529-41. PubMed ID: 21380606
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric characterization of tamoxifene metabolites in human urine utilizing different scan parameters on liquid chromatography/tandem mass spectrometry.
Mazzarino M; de la Torre X; Di Santo R; Fiacco I; Rosi F; Botrè F
Rapid Commun Mass Spectrom; 2010 Mar; 24(6):749-60. PubMed ID: 20187079
[TBL] [Abstract][Full Text] [Related]
5. Structural elucidation of new urinary tamoxifen metabolites by liquid chromatography quadrupole time-of-flight mass spectrometry.
Lu J; He C; He G; Wang X; Xu Y; Wu Y; Dong Y; Ouyang G
J Mass Spectrom; 2014 Jul; 49(7):570-8. PubMed ID: 25044841
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometric identification and characterization of new clomiphene metabolites in human urine by liquid chromatography-quadrupole time-of-flight tandem mass spectrometry.
Lu J; He G; Wang X; Xu Y; Wu Y; Dong Y; He Z; Liu X; Bo T; Ouyang G
J Chromatogr A; 2012 Jun; 1243():23-32. PubMed ID: 22579489
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS/(MS) following in vitro and excretion studies.
Mazzarino M; Biava M; de la Torre X; Fiacco I; Botrè F
Anal Bioanal Chem; 2013 Jun; 405(16):5467-87. PubMed ID: 23604525
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry.
Pozo OJ; Van Thuyne W; Deventer K; Van Eenoo P; Delbeke FT
J Mass Spectrom; 2008 Mar; 43(3):394-408. PubMed ID: 18035854
[TBL] [Abstract][Full Text] [Related]
9. Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry.
Pozo OJ; Van Eenoo P; Deventer K; Lootens L; Grimalt S; Sancho JV; Hernández F; Meuleman P; Leroux-Roels G; Delbeke FT
Steroids; 2009 Oct; 74(10-11):837-52. PubMed ID: 19464304
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W
Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598
[TBL] [Abstract][Full Text] [Related]
11. A mass spectrometric approach for the study of the metabolism of clomiphene, tamoxifen and toremifene by liquid chromatography time-of-flight spectroscopy.
Mazzarino M; Fiacco I; de la Torre X; Botrè F
Eur J Mass Spectrom (Chichester); 2008; 14(3):171-80. PubMed ID: 18708697
[TBL] [Abstract][Full Text] [Related]
12. Toremifene metabolism in rat, mouse and human liver microsomes: identification of alpha-hydroxytoremifene by LC-MS.
Jones RM; Lim CK
Biomed Chromatogr; 2002 Aug; 16(5):361-3. PubMed ID: 12210510
[TBL] [Abstract][Full Text] [Related]
13. Expanding sports drug testing assays: mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105.
Thevis M; Piper T; Beuck S; Geyer H; Schänzer W
Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1173-82. PubMed ID: 23650030
[TBL] [Abstract][Full Text] [Related]
14. A simplified procedure for the analysis of formoterol in human urine by liquid chromatography-electrospray tandem mass spectrometry: application to the characterization of the metabolic profile and stability of formoterol in urine.
Mazzarino M; de la Torre X; Fiacco I; Pompei C; Calabrese F; Botrè F
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():75-83. PubMed ID: 23777613
[TBL] [Abstract][Full Text] [Related]
15. Drug-drug interaction and doping, part 1: an in vitro study on the effect of non-prohibited drugs on the phase I metabolic profile of toremifene.
Mazzarino M; de la Torre X; Fiacco I; Palermo A; Botrè F
Drug Test Anal; 2014 May; 6(5):482-91. PubMed ID: 24431005
[TBL] [Abstract][Full Text] [Related]
16. Sulfate metabolites as alternative markers for the detection of 4-chlorometandienone misuse in doping control.
Balcells G; Gómez C; Garrostas L; Pozo ÓJ; Ventura R
Drug Test Anal; 2017 Jul; 9(7):983-993. PubMed ID: 27686240
[TBL] [Abstract][Full Text] [Related]
17. New clostebol metabolites in human urine by liquid chromatography time-of-flight tandem mass spectrometry and their application for doping control.
Lu J; Fernández-Álvarez M; Yang S; He G; Xu Y; Aguilera R
J Mass Spectrom; 2015 Jan; 50(1):191-7. PubMed ID: 25601692
[TBL] [Abstract][Full Text] [Related]
18. Study of tamoxifen urinary metabolites in rat by ultra-high-performance liquid chromatography time-of-flight mass spectrometry.
Domínguez-Romero JC; García-Reyes JF; Beneito-Cambra M; Martínez-Romero R; Martinez-Lara E; Del Moral-Leal ML; Molina-Díaz A
Biomed Chromatogr; 2015 Aug; 29(8):1220-8. PubMed ID: 25611330
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the in vitro metabolic profile of amlodipine in rat using liquid chromatography-mass spectrometry.
Suchanova B; Kostiainen R; Ketola RA
Eur J Pharm Sci; 2008 Jan; 33(1):91-9. PubMed ID: 18055188
[TBL] [Abstract][Full Text] [Related]
20. In vitro phase I metabolism of selective estrogen receptor modulators in horse using ultra-high performance liquid chromatography-high resolution mass spectrometry.
Kwok KY; Chan GHM; Kwok WH; Wong JKY; Wan TSM
Drug Test Anal; 2017 Sep; 9(9):1349-1362. PubMed ID: 28054434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
